Mortality of hospitalized drug users in the Czech Republic

被引:20
作者
Lejckova, Pavla
Mravcik, Viktor
机构
关键词
D O I
10.1177/002204260703700105
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug users are generally thought to experience higher mortality rates than those found among the general population. This study analyzes mortality rates among different subgroups of drug users in the Czech Republic. For this project, a retrospective cohort mortality study was conducted. A cohort of 12,207 persons aged 15 to 49 who had been hospitalized for drug related behavioral disorders was followed from 1997 to 2002. The study findings indicate that direct standardized mortality for the cohort of drug users was 16.78 per 1000 person-years (PY); 22.38 for men and 11.18 per 1000 PY for women. After reaching a peak in 1998, mortality rates began to decrease and stabilized around 14 per 1,000 PY from 2000 to 2002. When compared to the rates found in the general population, drug user mortality is eight times higher than nonuser rates (SMR = 8.15; 8.13 for men and 8.22 for women). These mortality rates are highest among polyvalent drug and opiate users and lowest among stimulant users. The authors conclude that the overall mortality of opiate users in the Czech Republic is relatively low when compared with those reported in similar European and non-European studies. There were few overdoses found in the cohort, and in sharp contrast to other available studies, no AIDS related cases were observed. © 2007 BY THE JOURNAL OF DRUG ISSUES.
引用
收藏
页码:103 / 118
页数:16
相关论文
共 29 条
[1]  
Bargagli A.M., Hickman M., Davoli M., Perucci C.A., Schifano P., Buster M., Brugal T., Vicente J., Drug-related mortality and its impact on adult mortality in eight European countries, European Journal of Public Health, 16, pp. 198-202, (2006)
[2]  
Bargagli A.M., Sperati A., Davoli M., Forastiere F., Perucci C.A., Mortality Among problem drug users in Rome: An 18-year follow-up study, 1980-97, Addiction, 96, pp. 1455-1463, (2001)
[3]  
Bartu A., Freeman N.C., Gawthorne G.S., Codde J.P., Holman C.D., Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia, Addiction, 99, pp. 53-60, (2004)
[4]  
Brugal T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L., Evaluating the Impact of Methadone Maintenance Programs on Mortality Due To Overdose and AIDS in a Cohort of Heroin Users in Spain, Addiction, 100, pp. 981-989, (2005)
[5]  
Ciccolallo L., Morandi G., Paravin R., Sorio C., Buiatti E., Mortality risk in intravenous drug users in Emilia Romagna Region and its socio-demographic determinants. Results of a longitudinal study, Epidemiologia e Prevenzione, 24, pp. 75-80, (2000)
[6]  
Davoli M., Perucci C.A., Rapiti E., Bargagli A.M., D'Ippoliti D., Forastiere F., Abeni D., A persistent rise in mortality among injection drug users in Rome, 1980 to 1992, American Journal of Public Health, 87, pp. 851-853, (1997)
[7]  
Davoli M., Perucci C.A., Forastiere F., Doyle P., Rapiti E., Zaccarelli M., Abeni D.D., Risk factors for overdose mortality: A case-control study within a cohort of intravenous drug users, International Journal of Epidemiology, 22, pp. 273-277, (1993)
[8]  
Mortality of drug users in the EU: Co-ordination of implementation of new cohort studies, follow-up and analysis of existing cohorts and development of new methods and outputs, EMCDDA Scientific Report, (2002)
[9]  
Frischer M., Goldberg D., Rahman M., Berney L., Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994, Addiction, 92, pp. 419-427, (1997)
[10]  
Galli M., Musicco M., Mortality of intravenous drug users living in Milan, Italy: Role of HIV-1 infection. COMCAT Study Group, AIDS, 8, pp. 1457-1463, (1994)